Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer
Huayan Gu,1,* Teng Zhu,2,* JiaLing Ding,1 Zhi Yang,1 Shuangyi Qi,1 Guilong Guo1 1Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Gastrointestinal Surgery, The First Affiliated Hospital of W...
Saved in:
| Main Authors: | Gu H, Zhu T, Ding J, Yang Z, Qi S, Guo G |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/real-world-analysis-of-the-efficacy-and-adverse-events-of-t-dm1-in-chi-peer-reviewed-fulltext-article-BCTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-DM1 with concurrent radiotherapy in HER2-positive breast cancer: preclinical evaluation and mechanisms, prediction, and exploration of adverse effects
by: Guangmin Wan, et al.
Published: (2025-05-01) -
Clinical characteristics, treatment, and survival of thrombocytopenia induced by T-DM1 in early HER2-positive breast cancer
by: Fang Wang, et al.
Published: (2025-07-01) -
A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast Cancer
by: Yang Z, et al.
Published: (2025-03-01) -
Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database
by: Jinming Han, et al.
Published: (2025-04-01) -
Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)